Your Health, We Care
Fidaxomicin, as an important antibacterial drug, holds a certain market share in the global market. With the deepening understanding of Clostridium difficile infection and the increasing demand for treatment, the market prospects of non fungicide are broad.
Fidaxomicin is a white to off-white film-coated oblong tablet and should be used as directed by a healthcare practitioner.How much do the different versions of Fidaxomicin cost?Pri···【more】
Article source：Lucius LaosRelease date：2024-08-28Recommended：181
Fidaxomicin works by inhibiting the RNA polymerase of bacteria, which has little damage to normal intestinal colonies and is highly safe.How many versions of Fidaxomicin are there?···【more】
Article source：Lucius LaosRelease date：2024-08-28Recommended：220
Fidaxomicin is a macrolide antibiotic developed by Optimer and approved by the FDA in 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD).What is Fidaxomicin···【more】
Article source：Lucius LaosRelease date：2024-08-28Recommended：262
Fidaxomicin received its initial approval from the Food and Drug Administration (FDA) in the United States in 2011 and has since been effectively commercialized. This article serve···【more】
Article source：Lucius LaosRelease date：2024-08-05Recommended：192
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
